Literature DB >> 15942432

Probiotics used in human studies.

David C Montrose1, Martin H Floch.   

Abstract

GOAL: To investigate the literature from 1980 to 2004 for the types of studies and organisms used as probiotics in human studies and diseases.
METHODS: PubMed search for probiotic organisms used in studies from 1980 to August 2004. The data from those papers were evaluated for organisms used, dose, vehicle, frequency, and investigator's report of positive or negative results.
RESULTS: A total of 185 manuscripts were identified. Investigators reported results of both single and multiple organisms in the same manuscript. A single organism was used in 125 reports, and multiple organisms, ranging from 2 to 9, were used in 60 reports. Positive results were reported in 239 clinical situations and negative results reported in 49 in a total of 288 clinical conclusions drawn by the respective investigators. The studies are tabulated in this review.
CONCLUSION: There is a large literature available in credible journals that report benefit of probiotic administration using a wide range of doses, organisms, and clinical situations. Most of the studies are simple reports of a clinical situation and require additional evaluation.

Entities:  

Mesh:

Year:  2005        PMID: 15942432     DOI: 10.1097/01.mcg.0000165649.32371.71

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  8 in total

Review 1.  Structural bacterial molecules as potential candidates for an evolution of the classical concept of probiotics.

Authors:  Michele Caselli; Giuseppina Vaira; Girolamo Calo; Francesco Papini; John Holton; Dino Vaira
Journal:  Adv Nutr       Date:  2011-09-06       Impact factor: 8.701

Review 2.  Probiotic use in irritable bowel syndrome.

Authors:  Patrick Young; Brooks D Cash
Journal:  Curr Gastroenterol Rep       Date:  2006-08

Review 3.  Probiotics for people with hepatic encephalopathy.

Authors:  Rohan Dalal; Richard G McGee; Stephen M Riordan; Angela C Webster
Journal:  Cochrane Database Syst Rev       Date:  2017-02-23

4.  A candidate probiotic with unfavourable effects in subjects with irritable bowel syndrome: a randomised controlled trial.

Authors:  Solveig C Ligaarden; Lars Axelsson; Kristine Naterstad; Stian Lydersen; Per G Farup
Journal:  BMC Gastroenterol       Date:  2010-02-10       Impact factor: 3.067

5.  Anti-inflammatory effect of bioflora probiotic administered orally or subcutaneously with live or dead bacteria.

Authors:  Om Laudanno; L Vasconcelos; J Catalana; Ja Cesolari
Journal:  Dig Dis Sci       Date:  2006-11-02       Impact factor: 3.487

6.  A randomised controlled trial of a probiotic 'functional food' in the management of irritable bowel syndrome.

Authors:  Lesley M Roberts; Deborah McCahon; Roger Holder; Sue Wilson; F D Richard Hobbs
Journal:  BMC Gastroenterol       Date:  2013-03-07       Impact factor: 3.067

7.  The Probiotic Escherichia coli Strain Nissle 1917 Combats Lambdoid Bacteriophages stx and λ.

Authors:  Susanne Bury; Manonmani Soundararajan; Richa Bharti; Rudolf von Bünau; Konrad U Förstner; Tobias A Oelschlaeger
Journal:  Front Microbiol       Date:  2018-05-29       Impact factor: 5.640

Review 8.  Helicobacter pylori: Perturbation and restoration of gut microbiome.

Authors:  Ankita Saxena; Asish Kumar Mukhopadhyay; Shoma Paul Nandi
Journal:  J Biosci       Date:  2020       Impact factor: 1.826

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.